Rothschild Capital Partners’s Gilead Sciences GILD Stock Holding History

Rothschild Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,700	Closed	-$248K	–	69
2016 Q1	$248K	Sell	2,700 -5,500	-67%	-$496K	0.11%	58
2015 Q4	$830K	Buy	8,200 +5,200	+173%	+$541K	0.42%	29
2015 Q3	$295K	Buy	3,000 +1,000	+50%	+$111K	0.15%	37
2015 Q2	$234K	Buy	+2,000	New	+$219K	0.1%	43
2015 Q1	–	Sell	-50	Closed	-$5K	–	43
2014 Q4	$5K	Hold	50	–	–	﹤0.01%	42
2014 Q3	$60K	Buy	+50	New	+$4.9K	0.03%	43
2014 Q2	–	Sell	-50	Closed	-$375K	–	44
2014 Q1	$375K	Buy	+50	New	+$3.92K	0.18%	34
2013 Q4	–	Sell	-10,000	Closed	-$81K	–	43
2013 Q3	$81K	Hold	10,000	–	–	0.04%	41
2013 Q2	$28K	Buy	+10,000	New	+$521K	0.02%	42

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rothschild Capital Partners's GILD Position: Q1 2016 in Review

Rothschild Capital Partners sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 1,700 shares — an estimated $153K sold.

Rothschild Capital Partners first reported a position in GILD in Q3 2014 and held it in 3 quarters. The position peaked at $707K in Q4 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Rothschild Capital Partners reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Rothschild Capital Partners sold 1,700 Gilead Sciences shares in Q1 2016, an estimated $153K.
Rothschild Capital Partners first reported a position in Gilead Sciences in Q3 2014 and held it in 3 quarters.
Rothschild Capital Partners's Gilead Sciences position peaked at $707K in Q4 2014.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Rothschild Capital Partners's 13F filing for Q1 2016, filed 4 May 2016.